TrialScientific reports2024

Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trials.

Sara A Almansour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.